
George J. Marlo
Examiner (ID: 10188)
| Most Active Art Unit | 3304 |
| Art Unit(s) | 2102, 3711, 3305, 3304 |
| Total Applications | 2473 |
| Issued Applications | 2233 |
| Pending Applications | 77 |
| Abandoned Applications | 163 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4337896
[patent_doc_number] => 06333332
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-25
[patent_title] => 'Stabilized pharmaceutical compositions containing bupropion hydrochloride'
[patent_app_type] => 1
[patent_app_number] => 9/645602
[patent_app_country] => US
[patent_app_date] => 2000-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3989
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/333/06333332.pdf
[firstpage_image] =>[orig_patent_app_number] => 645602
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/645602 | Stabilized pharmaceutical compositions containing bupropion hydrochloride | Aug 24, 2000 | Issued |
Array
(
[id] => 1139072
[patent_doc_number] => 06780880
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-24
[patent_title] => 'FT-Raman spectroscopic measurement'
[patent_app_type] => B1
[patent_app_number] => 09/649447
[patent_app_country] => US
[patent_app_date] => 2000-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6250
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/780/06780880.pdf
[firstpage_image] =>[orig_patent_app_number] => 09649447
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/649447 | FT-Raman spectroscopic measurement | Aug 24, 2000 | Issued |
Array
(
[id] => 4305525
[patent_doc_number] => 06326384
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'Dry blend pharmaceutical unit dosage form'
[patent_app_type] => 1
[patent_app_number] => 9/645148
[patent_app_country] => US
[patent_app_date] => 2000-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36119
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/326/06326384.pdf
[firstpage_image] =>[orig_patent_app_number] => 645148
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/645148 | Dry blend pharmaceutical unit dosage form | Aug 23, 2000 | Issued |
Array
(
[id] => 1446949
[patent_doc_number] => 06369087
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-09
[patent_title] => 'Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same'
[patent_app_type] => B1
[patent_app_number] => 09/645145
[patent_app_country] => US
[patent_app_date] => 2000-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35024
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 218
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/369/06369087.pdf
[firstpage_image] =>[orig_patent_app_number] => 09645145
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/645145 | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same | Aug 23, 2000 | Issued |
Array
(
[id] => 4288738
[patent_doc_number] => 06268385
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'Dry blend pharmaceutical formulations'
[patent_app_type] => 1
[patent_app_number] => 9/645146
[patent_app_country] => US
[patent_app_date] => 2000-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36316
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/268/06268385.pdf
[firstpage_image] =>[orig_patent_app_number] => 645146
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/645146 | Dry blend pharmaceutical formulations | Aug 23, 2000 | Issued |
| 09/645682 | Fullerene pharmaceutical compositions for preventing or treating disorders | Aug 23, 2000 | Abandoned |
Array
(
[id] => 1433418
[patent_doc_number] => 06340708
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-22
[patent_title] => 'Pharmaceutical composition comprising at least one aminopeptidase A inhibitor'
[patent_app_type] => B1
[patent_app_number] => 09/600238
[patent_app_country] => US
[patent_app_date] => 2000-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4644
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/340/06340708.pdf
[firstpage_image] =>[orig_patent_app_number] => 09600238
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/600238 | Pharmaceutical composition comprising at least one aminopeptidase A inhibitor | Aug 21, 2000 | Issued |
Array
(
[id] => 4305229
[patent_doc_number] => 06326366
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'Hormone replacement therapy'
[patent_app_type] => 1
[patent_app_number] => 9/643429
[patent_app_country] => US
[patent_app_date] => 2000-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9131
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/326/06326366.pdf
[firstpage_image] =>[orig_patent_app_number] => 643429
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/643429 | Hormone replacement therapy | Aug 21, 2000 | Issued |
Array
(
[id] => 1459127
[patent_doc_number] => 06426351
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-30
[patent_title] => 'Chelerythrine-based therapies for cancer'
[patent_app_type] => B1
[patent_app_number] => 09/637816
[patent_app_country] => US
[patent_app_date] => 2000-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 11895
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/426/06426351.pdf
[firstpage_image] =>[orig_patent_app_number] => 09637816
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/637816 | Chelerythrine-based therapies for cancer | Aug 10, 2000 | Issued |
Array
(
[id] => 4338880
[patent_doc_number] => 06284264
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-04
[patent_title] => 'Water soluble film for oral administration with instant wettability'
[patent_app_type] => 1
[patent_app_number] => 9/630562
[patent_app_country] => US
[patent_app_date] => 2000-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2433
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/284/06284264.pdf
[firstpage_image] =>[orig_patent_app_number] => 630562
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/630562 | Water soluble film for oral administration with instant wettability | Aug 1, 2000 | Issued |
Array
(
[id] => 4324620
[patent_doc_number] => 06312712
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => 'Method of improving bioavailability'
[patent_app_type] => 1
[patent_app_number] => 9/628840
[patent_app_country] => US
[patent_app_date] => 2000-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33024
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/312/06312712.pdf
[firstpage_image] =>[orig_patent_app_number] => 628840
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/628840 | Method of improving bioavailability | Jul 30, 2000 | Issued |
Array
(
[id] => 4305636
[patent_doc_number] => 06316020
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-13
[patent_title] => 'Pharmaceutical formulations'
[patent_app_type] => 1
[patent_app_number] => 9/629587
[patent_app_country] => US
[patent_app_date] => 2000-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32996
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/316/06316020.pdf
[firstpage_image] =>[orig_patent_app_number] => 629587
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/629587 | Pharmaceutical formulations | Jul 30, 2000 | Issued |
Array
(
[id] => 4324770
[patent_doc_number] => 06312723
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => 'Pharmaceutical unit dosage form'
[patent_app_type] => 1
[patent_app_number] => 9/629634
[patent_app_country] => US
[patent_app_date] => 2000-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32991
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/312/06312723.pdf
[firstpage_image] =>[orig_patent_app_number] => 629634
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/629634 | Pharmaceutical unit dosage form | Jul 30, 2000 | Issued |
Array
(
[id] => 4255193
[patent_doc_number] => 06207856
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-03-27
[patent_title] => 'Therapeutic compositions'
[patent_app_type] => 1
[patent_app_number] => 9/630007
[patent_app_country] => US
[patent_app_date] => 2000-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16584
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/207/06207856.pdf
[firstpage_image] =>[orig_patent_app_number] => 630007
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/630007 | Therapeutic compositions | Jul 30, 2000 | Issued |
Array
(
[id] => 4383977
[patent_doc_number] => 06262086
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-17
[patent_title] => 'Pharmaceutical unit dosage form'
[patent_app_type] => 1
[patent_app_number] => 9/630022
[patent_app_country] => US
[patent_app_date] => 2000-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33012
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/262/06262086.pdf
[firstpage_image] =>[orig_patent_app_number] => 630022
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/630022 | Pharmaceutical unit dosage form | Jul 30, 2000 | Issued |
Array
(
[id] => 4331060
[patent_doc_number] => 06313130
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => 'JAK-3 inhibitors for treating allergic disorders'
[patent_app_type] => 1
[patent_app_number] => 9/627342
[patent_app_country] => US
[patent_app_date] => 2000-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 54
[patent_no_of_words] => 20630
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/313/06313130.pdf
[firstpage_image] =>[orig_patent_app_number] => 627342
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/627342 | JAK-3 inhibitors for treating allergic disorders | Jul 27, 2000 | Issued |
Array
(
[id] => 1602812
[patent_doc_number] => 06432991
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-13
[patent_title] => 'Methods of treatment using MAO-A and MAO-B inhibitors such as L-deprenyl'
[patent_app_type] => B1
[patent_app_number] => 09/881199
[patent_app_country] => US
[patent_app_date] => 2000-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6008
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/432/06432991.pdf
[firstpage_image] =>[orig_patent_app_number] => 09881199
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/881199 | Methods of treatment using MAO-A and MAO-B inhibitors such as L-deprenyl | Jul 26, 2000 | Issued |
Array
(
[id] => 4409322
[patent_doc_number] => 06239165
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-29
[patent_title] => 'Liquid pharmaceutical formulation containing zotepine'
[patent_app_type] => 1
[patent_app_number] => 9/600980
[patent_app_country] => US
[patent_app_date] => 2000-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2999
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/239/06239165.pdf
[firstpage_image] =>[orig_patent_app_number] => 600980
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/600980 | Liquid pharmaceutical formulation containing zotepine | Jul 24, 2000 | Issued |
| 09/616812 | Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds | Jul 13, 2000 | Abandoned |
Array
(
[id] => 4379981
[patent_doc_number] => 06303595
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-16
[patent_title] => 'Use of mirtazapine for treating sleep apneas'
[patent_app_type] => 1
[patent_app_number] => 9/554143
[patent_app_country] => US
[patent_app_date] => 2000-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1564
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/303/06303595.pdf
[firstpage_image] =>[orig_patent_app_number] => 554143
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/554143 | Use of mirtazapine for treating sleep apneas | Jul 13, 2000 | Issued |